Sudhir Srivastava

Last updated

Sudhir Srivastava
Occupation Scientist

Sudhir Srivastava is chief of the Cancer Biomarkers Research Group of the Division of Cancer Prevention at the United States NCI. [1] [2] Srivastava has held this position since 2000. He is a co-author of the Bethesda Guidelines for the diagnosis of Hereditary non-polyposis colorectal cancer (HNPCC). [1]

Srivastava is an elected member of the American Joint Committee on Cancer (AJCC), responsible for developing cancer staging criteria, and serves on the AJCC Executive Committee and the All Ireland-NCI Consortium. [3] Srivastava is a founding member of HUPO, participated in the Plasma Proteome and the Liver Proteome Projects, and supported several HUPO-supported initiatives. [4]


References

  1. 1 2 "Division of Cancer Prevention Staff: Sudhir Srivastava". Archived from the original on 26 June 2013.
  2. ↑ "Cancer Biomarkers Research Group". Archived from the original on 8 October 2012.
  3. ↑ "All Ireland-NCI Consortium".
  4. ↑ "HUPO-supported initiatives". Archived from the original on 15 April 2013.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.